Impact BioMedical, Inc. IBO 深 沪
已收盘 02-06 16:00:00 美东时间
0.4717
-0.014
-2.98%
华盛通- 最 高0.5005
- 今 开0.4601
- 成交量 4.96万股
- 最 低 0.459
- 昨 收 0.4862
- 总市值 4934.98万
- 52周最高 6.17
- 市盈率 静 --
- 换手率 0.05%
- 52周最低 0.3621
- 委 比 1.54%
- 总股本 1.05亿
- 历史最高 6.17
- 量 比 0.61
- 振 幅 8.54%
- 历史最低 0.3621
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock rose 10.2% to $2.8 during Wedn...
2025-11-20 05:07
Universal Ibogaine Inc. to File Clinical Trial Application for Ibogaine Treatment
Universal Ibogaine Inc ( ($TSE:IBO) ) has issued an update. Universal Ibogaine ...
2025-09-05 07:37
Impact Biomedical announces 3F US patent issue
Impact Biomedical (NYSE:IBO) announced on Monday that the US Patent and Trademark Office has issued a patent titled “Composition and Method of Controlling Infectious Diseases with Functional Fragrance...
2025-08-18 21:07
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
Impact Biomedical Inc. (IBO) announces the issuance of U.S. Patent No. 12,357,584 B2 for a method and composition using plant-derived functional fragrances to control infectious diseases. This invention, developed under IBO’s 3F™ technology platform, demonstrates potential as an antibacterial and antiviral agent, with applications against pathogens like E. coli, MRSA, influenza, and more. The patent expands IBO’s portfolio and underscores its com...
2025-08-18 12:30
Impact BioMedical Q2 EPS $(1.18), Sales $7.00K
Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this quarter.
2025-08-15 05:48
Impact BioMedical Finalizes Debt Conversion Agreement
An update from Impact BioMedical, Inc. ( ($IBO) ) is now available. On July 21,...
2025-07-28 23:30
Impact BioMedical Says On July 21, 2025, Co Converted $12M Debt To Equity With DSS Through Issuance Of 31.9M Shares
On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into a Debt Conversion Agreement with DSS, Inc. ("DSS" or "Lender"), pursuant to that certain loan made on March 31, 2023, by the Lender in
2025-07-28 23:11
Universal Ibogaine Announces CFO Departure Amidst Strategic Developments
Universal Ibogaine Inc ( ($TSE:IBO) ) just unveiled an announcement. Universal ...
2025-07-17 08:32
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of BlackBerry Limited (NYSE:BB) rose sharply in today's pre-market tradi...
2025-06-25 17:43
Why Is Impact BioMedical Stock (IBO) Up 200% Today?
Impact BioMedical stock soared on Monday after the company announced a merger a...
2025-06-24 09:29
